82_FR_60648 82 FR 60405 - Agency Information Collection Activities: Proposed Collection; Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery

82 FR 60405 - Agency Information Collection Activities: Proposed Collection; Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 82, Issue 243 (December 20, 2017)

Page Range60405-60406
FR Document2017-27399

Department of Health and Human Services, The Office of the Secretary (OS), as part of its continuing effort to reduce paperwork and respondent burden, invites the general public to take this opportunity to comment on the ``Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery'' for approval under the Paperwork Reduction Act (PRA). This collection was developed as part of a Federal Government-wide effort to streamline the process for seeking feedback from the public on service delivery. This notice announces our intent to submit this collection to OMB for approval and solicits comments on specific aspects for the proposed information collection.

Federal Register, Volume 82 Issue 243 (Wednesday, December 20, 2017)
[Federal Register Volume 82, Number 243 (Wednesday, December 20, 2017)]
[Notices]
[Pages 60405-60406]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-27399]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Agency Information Collection Activities: Proposed Collection; 
Comment Request; Generic Clearance for the Collection of Qualitative 
Feedback on Agency Service Delivery

AGENCY: U.S. Department of Health and Human Services.

ACTION: 30-Day Day Notice template for Request for Generic Clearance 
for the Collection of Routine Customer Feedback on (HITRC).

-----------------------------------------------------------------------

AGENCY: U.S. Department of Health and Human Services (HHS).

ACTION: Notice and request for comments. Office of the National 
Coordinator for Health Information Technology is requesting OMB 
approval for an extension on the Generic Clearance for the Collection 
of Routine Customer Feedback by OMB.

-----------------------------------------------------------------------

SUMMARY: Department of Health and Human Services, The Office of the 
Secretary (OS), as part of its continuing effort to reduce paperwork 
and respondent burden, invites the general public to take this 
opportunity to comment on the ``Generic Clearance for the Collection of 
Qualitative Feedback on Agency Service Delivery'' for approval under 
the Paperwork Reduction Act (PRA). This collection was developed as 
part of a Federal Government-wide effort to streamline the process for 
seeking feedback from the public on service delivery. This notice 
announces our intent to submit this collection to OMB for approval and 
solicits comments on specific aspects for the proposed information 
collection.

DATES: Consideration will be given to all comments received by January 
19, 2018.

ADDRESSES: Submit comments by one of the following methods:
     Website: www.regulations.gov. Direct comments to Docket ID 
OMB-2010-0021.
     Email: [email protected].
     Phone: (202) 795-7714.
    Comments submitted in response to this notice may be made available 
to the public through relevant websites. For this reason, please do not 
include in your comments information of a confidential nature, such as 
sensitive personal information or proprietary information. If you send 
an email comment, your email address will be automatically captured and 
included as part of the comment that is placed in the public docket and 
made available on the internet. Please note that responses to this 
public comment request containing any routine notice about the 
confidentiality of the communication will be treated as public comments 
that may be made available to the public notwithstanding the inclusion 
of the routine notice.

FOR FURTHER INFORMATION CONTACT: Sherrette Funn, 
[email protected] or (202) 795-7714.

SUPPLEMENTARY INFORMATION: 
    Title: Generic Clearance for the Collection of Qualitative Feedback 
on Agency Service Delivery.
    Abstract: The proposed information collection activity provides a 
means to garner qualitative customer and stakeholder feedback in an 
efficient, timely manner, in accordance with the Administration's 
commitment to improving service delivery. By qualitative feedback we 
mean information that provides useful insights on perceptions and 
opinions, but are not statistical surveys that yield quantitative 
results that can be generalized to the population of study. This 
feedback will provide insights into customer or stakeholder 
perceptions, experiences and expectations, provide an early warning of 
issues with service, or focus attention on areas where communication, 
training or changes in operations might improve delivery of products or 
services. These collections will allow for ongoing, collaborative and 
actionable communications between the Agency and its customers and 
stakeholders. It will also allow feedback to contribute directly to the 
improvement of program management.
    The solicitation of feedback will target areas such as: Timeliness, 
appropriateness, accuracy of information, courtesy, efficiency of 
service delivery, and resolution of issues with service delivery. 
Responses will be assessed to plan and inform efforts to improve or 
maintain the quality of service offered to the public. If this 
information is not collected, vital feedback from customers and 
stakeholders on the Agency's services will be unavailable.
    The Agency will only submit a collection for approval under this 
generic clearance if it meets the following conditions:
     The collections are voluntary;
     The collections are low-burden for respondents (based on 
considerations of total burden hours, total number of respondents, or 
burden-hours per respondent) and are low-cost for both the respondents 
and the Federal Government;
     The collections are non-controversial and do not raise 
issues of concern to other Federal agencies;

[[Page 60406]]

     Any collection is targeted to the solicitation of opinions 
from respondents who have experience with the program or may have 
experience with the program in the near future;
     Personally identifiable information (PII) is collected 
only to the extent necessary and is not retained;
     Information gathered will be used only internally for 
general service improvement and program management purposes and is not 
intended for release outside of the agency;
     Information gathered will not be used for the purpose of 
substantially informing influential policy decisions; and
     Information gathered will yield qualitative information; 
the collections will not be designed or expected to yield statistically 
reliable results or used as though the results are generalizable to the 
population of study.
    Feedback collected under this generic clearance provides useful 
information, but it does not yield data that can be generalized to the 
overall population. This type of generic clearance for qualitative 
information will not be used for quantitative information collections 
that are designed to yield reliably actionable results, such as 
monitoring trends over time or documenting program performance. Such 
data uses require more rigorous designs that address: The target 
population to which generalizations will be made, the sampling frame, 
the sample design (including stratification and clustering), the 
precision requirements or power calculations that justify the proposed 
sample size, the expected response rate, methods for assessing 
potential non-response bias, the protocols for data collection, and any 
testing procedures that were or will be undertaken prior to fielding 
the study. Depending on the degree of influence the results are likely 
to have, such collections may still be eligible for submission for 
other generic mechanisms that are designed to yield quantitative 
results.
    As a general matter, information collections will not result in any 
new system of records containing privacy information and will not ask 
questions of a sensitive nature, such as sexual behavior and attitudes, 
religious beliefs, and other matters that are commonly considered 
private.
    Current Actions: Extension of approval for a collection of 
information.
    Type of Review: Extension.
    Affected Public: Individuals, households, professionals, public/
private sector.
    Estimated Number of Respondents:
    Below we provide projected average estimates for the next three 
years:
    Average Expected Annual Number of activities: 7.
    Average number of Respondents per Activity: 350.
    Annual responses: 4,158.
    Frequency of Response: Once per request.
    Average minutes per response: 5.
    Burden hours: 1,041.
    Request for Comments: Comments submitted in response to this notice 
will be summarized and/or included in the request for OMB approval. 
Comments are invited on: (a) Whether the collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information shall have practical utility; (b) the 
accuracy of the agency's estimate of the burden of the collection of 
information; (c) ways to enhance the quality, utility, and clarity of 
the information to be collected; (d) ways to minimize the burden of the 
collection of information on respondents, including through the use of 
automated collection techniques or other forms of information 
technology; and (e) estimates of capital or start-up costs and costs of 
operation, maintenance, and purchase of services to provide 
information. Burden means the total time, effort, or financial 
resources expended by persons to generate, maintain, retain, disclose 
or provide information to or for a Federal agency. This includes the 
time needed to review instructions; to develop, acquire, install and 
utilize technology and systems for the purpose of collecting, 
validating and verifying information, processing and maintaining 
information, and disclosing and providing information; to train 
personnel and to be able to respond to a collection of information, to 
search data sources, to complete and review the collection of 
information; and to transmit or otherwise disclose the information.
    All written comments will be available for public inspection 
Regulations.gov.
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless it displays a 
currently valid Office of Management and Budget control number.

Terry S. Clark,
Asst. Information Collection Clearance Officer.
[FR Doc. 2017-27399 Filed 12-19-17; 8:45 am]
 BILLING CODE 4150-45-P



                                                                         Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices                                            60405

                                                framework for such products (Docket                     DEPARTMENT OF HEALTH AND                              this public comment request containing
                                                No. FDA–2015–N–0540; available at                       HUMAN SERVICES                                        any routine notice about the
                                                https://www.regulations.gov/docket?D=                                                                         confidentiality of the communication
                                                FDA-2015-N-0540). FDA sought broad                      Agency Information Collection                         will be treated as public comments that
                                                public input on its enforcement policies                Activities: Proposed Collection;                      may be made available to the public
                                                related to drug products labeled as                     Comment Request; Generic Clearance                    notwithstanding the inclusion of the
                                                homeopathic in an effort to better                      for the Collection of Qualitative                     routine notice.
                                                promote and protect the public health.                  Feedback on Agency Service Delivery                   FOR FURTHER INFORMATION CONTACT:
                                                                                                        AGENCY:  U.S. Department of Health and                Sherrette Funn, Sherrrette.funn@
                                                   As a result of the Agency’s evaluation,                                                                    HHS.GOV or (202) 795–7714.
                                                including consideration of the public                   Human Services.
                                                                                                                                                              SUPPLEMENTARY INFORMATION:
                                                input received on this issue, FDA has                   ACTION: 30-Day Day Notice template for
                                                                                                                                                                 Title: Generic Clearance for the
                                                determined that it is in the best interest              Request for Generic Clearance for the
                                                                                                                                                              Collection of Qualitative Feedback on
                                                of public health to issue a new guidance                Collection of Routine Customer
                                                                                                                                                              Agency Service Delivery.
                                                that applies a risk-based enforcement                   Feedback on (HITRC).                                     Abstract: The proposed information
                                                approach to drug products labeled as                    AGENCY:  U.S. Department of Health and                collection activity provides a means to
                                                homeopathic and marketed in the                         Human Services (HHS).                                 garner qualitative customer and
                                                United States without the required FDA                                                                        stakeholder feedback in an efficient,
                                                                                                        ACTION: Notice and request for
                                                approval, consistent with FDA’s risk-                                                                         timely manner, in accordance with the
                                                                                                        comments. Office of the National
                                                based regulatory approaches generally.                                                                        Administration’s commitment to
                                                                                                        Coordinator for Health Information
                                                The Agency generally intends to apply                                                                         improving service delivery. By
                                                                                                        Technology is requesting OMB approval
                                                a risk-based enforcement approach to                                                                          qualitative feedback we mean
                                                                                                        for an extension on the Generic
                                                the manufacturing, distribution, and                                                                          information that provides useful
                                                                                                        Clearance for the Collection of Routine
                                                marketing of drug products labeled as                                                                         insights on perceptions and opinions,
                                                                                                        Customer Feedback by OMB.
                                                homeopathic, as described in the draft                                                                        but are not statistical surveys that yield
                                                guidance, when finalized. However, the                  SUMMARY:    Department of Health and                  quantitative results that can be
                                                Agency has limited enforcement                          Human Services, The Office of the                     generalized to the population of study.
                                                                                                        Secretary (OS), as part of its continuing             This feedback will provide insights into
                                                resources and recognizes that many
                                                                                                        effort to reduce paperwork and                        customer or stakeholder perceptions,
                                                such products likely will fall outside the
                                                                                                        respondent burden, invites the general                experiences and expectations, provide
                                                risk-based categories described in the                                                                        an early warning of issues with service,
                                                draft guidance.                                         public to take this opportunity to
                                                                                                        comment on the ‘‘Generic Clearance for                or focus attention on areas where
                                                   This draft guidance is being issued                  the Collection of Qualitative Feedback                communication, training or changes in
                                                consistent with FDA’s good guidance                     on Agency Service Delivery’’ for                      operations might improve delivery of
                                                practices regulation (21 CFR 10.115).                   approval under the Paperwork                          products or services. These collections
                                                The draft guidance, when finalized, will                Reduction Act (PRA). This collection                  will allow for ongoing, collaborative and
                                                represent the current thinking of FDA                   was developed as part of a Federal                    actionable communications between the
                                                on drug products labeled as                             Government-wide effort to streamline                  Agency and its customers and
                                                homeopathic. It does not establish any                  the process for seeking feedback from                 stakeholders. It will also allow feedback
                                                rights for any person and is not binding                the public on service delivery. This                  to contribute directly to the
                                                on FDA or the public. You can use an                    notice announces our intent to submit                 improvement of program management.
                                                                                                                                                                 The solicitation of feedback will target
                                                alternative approach if it satisfies the                this collection to OMB for approval and
                                                                                                                                                              areas such as: Timeliness,
                                                requirements of the applicable statutes                 solicits comments on specific aspects
                                                                                                                                                              appropriateness, accuracy of
                                                and regulations. This guidance is not                   for the proposed information collection.
                                                                                                                                                              information, courtesy, efficiency of
                                                subject to Executive Order 12866.                       DATES: Consideration will be given to all             service delivery, and resolution of
                                                                                                        comments received by January 19, 2018.                issues with service delivery. Responses
                                                II. Electronic Access
                                                                                                        ADDRESSES: Submit comments by one of                  will be assessed to plan and inform
                                                  Persons with access to the internet                   the following methods:                                efforts to improve or maintain the
                                                may obtain the draft guidance at either                    • Website: www.regulations.gov.                    quality of service offered to the public.
                                                https://www.fda.gov/Drugs/Guidance                      Direct comments to Docket ID OMB–                     If this information is not collected, vital
                                                ComplianceRegulatoryInformation/                        2010–0021.                                            feedback from customers and
                                                Guidances/default.htm, https://                            • Email:                                           stakeholders on the Agency’s services
                                                                                                        Information.CollectionClearance@                      will be unavailable.
                                                www.fda.gov/BiologicsBloodVaccines/
                                                                                                        hhs.gov.                                                 The Agency will only submit a
                                                GuidanceComplianceRegulatory
                                                                                                           • Phone: (202) 795–7714.                           collection for approval under this
                                                Information/Guidances/default.htm, or                      Comments submitted in response to
                                                https://www.regulations.gov.                                                                                  generic clearance if it meets the
                                                                                                        this notice may be made available to the              following conditions:
                                                  Dated: December 6, 2017.                              public through relevant websites. For                    • The collections are voluntary;
                                                Leslie Kux,                                             this reason, please do not include in                    • The collections are low-burden for
                                                Associate Commissioner for Policy.                      your comments information of a                        respondents (based on considerations of
                                                                                                        confidential nature, such as sensitive
sradovich on DSK3GMQ082PROD with NOTICES




                                                [FR Doc. 2017–27157 Filed 12–18–17; 11:15 am]
                                                                                                                                                              total burden hours, total number of
                                                                                                        personal information or proprietary                   respondents, or burden-hours per
                                                BILLING CODE 4164–01–P
                                                                                                        information. If you send an email                     respondent) and are low-cost for both
                                                                                                        comment, your email address will be                   the respondents and the Federal
                                                                                                        automatically captured and included as                Government;
                                                                                                        part of the comment that is placed in the                • The collections are non-
                                                                                                        public docket and made available on the               controversial and do not raise issues of
                                                                                                        internet. Please note that responses to               concern to other Federal agencies;


                                           VerDate Sep<11>2014   21:36 Dec 19, 2017   Jkt 244001   PO 00000   Frm 00037   Fmt 4703   Sfmt 4703   E:\FR\FM\20DEN1.SGM   20DEN1


                                                60406                    Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices

                                                   • Any collection is targeted to the                     Average Expected Annual Number of                  DEPARTMENT OF HEALTH AND
                                                solicitation of opinions from                           activities: 7.                                        HUMAN SERVICES
                                                respondents who have experience with                       Average number of Respondents per
                                                the program or may have experience                                                                            National Institutes of Health
                                                                                                        Activity: 350.
                                                with the program in the near future;
                                                   • Personally identifiable information                   Annual responses: 4,158.                           Prospective Grant of an Exclusive
                                                (PII) is collected only to the extent                      Frequency of Response: Once per                    Patent License: The Development of an
                                                necessary and is not retained;                          request.                                              Anti-CD30 Chimeric Antigen Receptor
                                                   • Information gathered will be used                                                                        (CAR) for the Treatment of Human
                                                                                                           Average minutes per response: 5.                   Cancer
                                                only internally for general service
                                                improvement and program management                         Burden hours: 1,041.
                                                                                                                                                              AGENCY:   National Institutes of Health
                                                purposes and is not intended for release                   Request for Comments: Comments                     ACTION:   Notice.
                                                outside of the agency;                                  submitted in response to this notice will
                                                   • Information gathered will not be                   be summarized and/or included in the                  SUMMARY:    The National Cancer Institute,
                                                used for the purpose of substantially                   request for OMB approval. Comments                    an institute of the National Institutes of
                                                informing influential policy decisions;                 are invited on: (a) Whether the                       Health, Department of Health and
                                                and                                                     collection of information is necessary                Human Services, is contemplating the
                                                   • Information gathered will yield                    for the proper performance of the                     grant of an Exclusive Patent License to
                                                qualitative information; the collections                functions of the agency, including                    practice the inventions embodied in the
                                                will not be designed or expected to                     whether the information shall have                    Patents and Patent Applications listed
                                                yield statistically reliable results or used                                                                  in the SUPPLEMENTARY INFORMATION
                                                                                                        practical utility; (b) the accuracy of the
                                                as though the results are generalizable to                                                                    section of this notice to Kite Pharma,
                                                                                                        agency’s estimate of the burden of the
                                                the population of study.                                                                                      Inc. (‘‘Kite’’) located in Santa Monica,
                                                   Feedback collected under this generic                collection of information; (c) ways to
                                                                                                        enhance the quality, utility, and clarity             CA.
                                                clearance provides useful information,
                                                                                                        of the information to be collected; (d)               DATES: Only written comments and/or
                                                but it does not yield data that can be
                                                                                                        ways to minimize the burden of the                    complete applications for a license
                                                generalized to the overall population.
                                                                                                        collection of information on                          which are received by the National
                                                This type of generic clearance for
                                                                                                        respondents, including through the use                Cancer Institute’s Technology Transfer
                                                qualitative information will not be used
                                                                                                        of automated collection techniques or                 Center on or before January 4, 2018 will
                                                for quantitative information collections
                                                                                                        other forms of information technology;                be considered.
                                                that are designed to yield reliably
                                                actionable results, such as monitoring                  and (e) estimates of capital or start-up              ADDRESSES: Requests for copies of the
                                                trends over time or documenting                         costs and costs of operation,                         patent application, inquiries, and
                                                program performance. Such data uses                     maintenance, and purchase of services                 comments relating to the contemplated
                                                require more rigorous designs that                      to provide information. Burden means                  Exclusive Patent License should be
                                                address: The target population to which                 the total time, effort, or financial                  directed to: David A. Lambertson, Ph.D.,
                                                generalizations will be made, the                       resources expended by persons to                      Senior Technology Transfer Manager,
                                                sampling frame, the sample design                       generate, maintain, retain, disclose or               NCI Technology Transfer Center, 9609
                                                (including stratification and clustering),              provide information to or for a Federal               Medical Center Drive, RM 1E530, MSC
                                                the precision requirements or power                     agency. This includes the time needed                 9702, Bethesda, MD 20892–9702 (for
                                                calculations that justify the proposed                  to review instructions; to develop,                   business mail), Rockville, MD 20850–
                                                sample size, the expected response rate,                acquire, install and utilize technology               9702; Telephone: (240)–276–5530;
                                                methods for assessing potential non-                    and systems for the purpose of                        Facsimile: (240)–276–5504; Email:
                                                response bias, the protocols for data                   collecting, validating and verifying                  david.lambertson@nih.gov.
                                                collection, and any testing procedures                  information, processing and                           SUPPLEMENTARY INFORMATION:
                                                that were or will be undertaken prior to                maintaining information, and disclosing               Intellectual Property
                                                fielding the study. Depending on the                    and providing information; to train
                                                degree of influence the results are likely              personnel and to be able to respond to                   United States Provisional Patent
                                                to have, such collections may still be                  a collection of information, to search                Application No. 62/241,896, filed 15
                                                eligible for submission for other generic               data sources, to complete and review                  October 2015 and entitled ‘‘Anti-CD30
                                                mechanisms that are designed to yield                   the collection of information; and to                 Chimeric Antigen Receptors’’ [HHS
                                                quantitative results.                                   transmit or otherwise disclose the                    Reference No. E–016–2018/0–US–01];
                                                   As a general matter, information                     information.                                          PCT Patent Application PCT/US2016/
                                                collections will not result in any new                                                                        056262, filed 10 October 2016 and
                                                                                                           All written comments will be                       entitled ‘‘Anti-CD30 Chimeric Antigen
                                                system of records containing privacy                    available for public inspection
                                                information and will not ask questions                                                                        Receptors’’ [HHS Reference No. E–016–
                                                                                                        Regulations.gov.                                      2018/0–PCT–02]; and U.S. and foreign
                                                of a sensitive nature, such as sexual
                                                behavior and attitudes, religious beliefs,                 An agency may not conduct or                       patent applications claiming priority to
                                                and other matters that are commonly                     sponsor, and a person is not required to              the aforementioned applications.
                                                considered private.                                     respond to, a collection of information                  The patent rights in these inventions
                                                   Current Actions: Extension of                        unless it displays a currently valid                  have been assigned and/or exclusively
                                                                                                        Office of Management and Budget                       licensed to the government of the
sradovich on DSK3GMQ082PROD with NOTICES




                                                approval for a collection of information.
                                                   Type of Review: Extension.                           control number.                                       United States of America.
                                                   Affected Public: Individuals,                                                                                 The prospective exclusive license
                                                                                                        Terry S. Clark,                                       territory may be worldwide and the
                                                households, professionals, public/
                                                private sector.                                         Asst. Information Collection Clearance                field of use may be limited to the
                                                   Estimated Number of Respondents:                     Officer.                                              following:
                                                   Below we provide projected average                   [FR Doc. 2017–27399 Filed 12–19–17; 8:45 am]            ‘‘The development of a CD30 chimeric
                                                estimates for the next three years:                     BILLING CODE 4150–45–P                                antigen receptor (CAR)-based



                                           VerDate Sep<11>2014   21:36 Dec 19, 2017   Jkt 244001   PO 00000   Frm 00038   Fmt 4703   Sfmt 4703   E:\FR\FM\20DEN1.SGM   20DEN1



Document Created: 2018-10-25 10:57:28
Document Modified: 2018-10-25 10:57:28
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
Action30-Day Day Notice template for Request for Generic Clearance for the Collection of Routine Customer Feedback on (HITRC).
DatesConsideration will be given to all comments received by January 19, 2018.
ContactSherrette Funn, [email protected] or (202) 795-7714.
FR Citation82 FR 60405 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR